The GLP-1 analogue liraglutide improves first-phase insulin secretion and maximal beta-cell secretory capacity over 14 weeks of therapy in subjects with Type 2 diabetes

Sten Madsbad, Tina Vilsbøll, Birgitte Brock, Hans Jørgen Duckert Perrild, Hans Henrik Lervang, Klaus Erik Kølendorf, Thure Krarup, Ole Schmitz, M Zdravkovic, T Le-Thi

Fingerprint

Dive into the research topics of 'The GLP-1 analogue liraglutide improves first-phase insulin secretion and maximal beta-cell secretory capacity over 14 weeks of therapy in subjects with Type 2 diabetes'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry